BRPI0406795A - Composições antiprotozoários que compreendem diclazuril - Google Patents

Composições antiprotozoários que compreendem diclazuril

Info

Publication number
BRPI0406795A
BRPI0406795A BR0406795-9A BRPI0406795A BRPI0406795A BR PI0406795 A BRPI0406795 A BR PI0406795A BR PI0406795 A BRPI0406795 A BR PI0406795A BR PI0406795 A BRPI0406795 A BR PI0406795A
Authority
BR
Brazil
Prior art keywords
protozoal
compositions
diclazuril
antiprotozoal
antiprotozoal compositions
Prior art date
Application number
BR0406795-9A
Other languages
English (en)
Inventor
Bart De Spiegeleer
Hilde Dosogne
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0406795A publication Critical patent/BRPI0406795A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

"COMPOSIçõES ANTIPROTOZOáRIOS QUE COMPREENDEM DICLAZURIL". A presente invenção refere-se a composições adequadas para administração oral, transdermal ou parenteral (por exemplo intranasal, intra-muscular, subcutânea ou intravenosa), em que a composição é compreendida de pelo menos um agente antiprotozoário dissolvido em uma mistura de um sistema de solvente à base de álcool, um sistema emulsificante e um sistema-base. Também é fornecido um processo para a preparação das ditas composições antiprotozoários e o seu uso no tratamento ou na prevenção de infecções por protozoários em animais de sangue quente, inclusive em seres humanos.
BR0406795-9A 2003-01-16 2004-01-09 Composições antiprotozoários que compreendem diclazuril BRPI0406795A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP0300398 2003-01-16
PCT/EP2004/000147 WO2004062673A1 (en) 2003-01-16 2004-01-09 Anti-protozoal compositions comprising diclazuril

Publications (1)

Publication Number Publication Date
BRPI0406795A true BRPI0406795A (pt) 2006-01-17

Family

ID=32695546

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406795-9A BRPI0406795A (pt) 2003-01-16 2004-01-09 Composições antiprotozoários que compreendem diclazuril

Country Status (11)

Country Link
US (1) US20060240049A1 (pt)
KR (1) KR20050091062A (pt)
AT (1) ATE376422T1 (pt)
BR (1) BRPI0406795A (pt)
CA (1) CA2512176A1 (pt)
DE (1) DE602004009664D1 (pt)
MX (1) MXPA05007601A (pt)
MY (1) MY141593A (pt)
PL (1) PL378713A1 (pt)
TW (1) TW200507873A (pt)
WO (1) WO2004062673A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
KR100683193B1 (ko) 2005-07-30 2007-02-15 주식회사유한양행 디클라주릴-함유 약제학적 조성물의 제조방법
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
CN102743334A (zh) * 2012-07-30 2012-10-24 郑州后羿制药有限公司 一种妥曲珠利注射剂及其制备方法
CN102973496B (zh) * 2012-11-22 2014-12-17 青岛绿曼生物工程有限公司 一种治疗家禽球虫病的地克珠利口服液的制备方法
CN105213311A (zh) * 2015-11-05 2016-01-06 南阳农业职业学院 地克珠利亚微乳的制备方法
BR112019000585A2 (pt) * 2016-07-13 2019-07-02 Hopitaux Paris Assist Publique derivados de meclozina e derivados de diclazuril para uso na prevenção e/ou no tratamento de distúrbios associados à inflamação induzida por p. acnes
US10702475B2 (en) 2017-09-05 2020-07-07 Richard Rigg Liposome containing compositions and their use in personal care and food products
CN108904514B (zh) * 2018-07-26 2021-03-26 日照市牧邦畜牧科技有限公司 一种稳定长效复方地克珠利溶液

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3703103A1 (de) * 1987-02-03 1988-08-11 Bayer Ag Mittel gegen fischparsiten
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
CA2285477C (en) * 1997-03-31 2006-10-10 The University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma

Also Published As

Publication number Publication date
DE602004009664D1 (de) 2007-12-06
ATE376422T1 (de) 2007-11-15
TW200507873A (en) 2005-03-01
US20060240049A1 (en) 2006-10-26
KR20050091062A (ko) 2005-09-14
MY141593A (en) 2010-05-14
CA2512176A1 (en) 2004-07-29
MXPA05007601A (es) 2005-09-30
WO2004062673A1 (en) 2004-07-29
PL378713A1 (pl) 2006-05-15

Similar Documents

Publication Publication Date Title
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
TW200621233A (en) HCV NS3-NS4A protease inhibition
BRPI0414176A (pt) inibidores de serina proteases, em particular hcv ns3-ns4a protease
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
NZ504986A (en) Erythromycin and azalide derivatives and pharmaceutical compositions thereof, useful as antibacterial agents and antoprotozoa agents
MX2007007598A (es) Macrolidos.
EA200200778A1 (ru) СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С В ОРГАНИЗМЕ ХОЗЯИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ПРОТИВ ФЛАВИВИРУСА, СОЕДИНЕНИЕ ФОРМУЛЫ Ib - АКТИВНЫЙ АГЕНТ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С ИЛИ ФЛАВИВИРУСА (ВАРИАНТЫ)
CR20220675A (es) Análogos de nucleósido de 1´- ciano y usos de los mismos
TN2009000481A1 (en) Novel peptide inhibitors of hepatitis c virus replication
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
CL2008001782A1 (es) Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion.
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
DK1581235T3 (da) Anvendelse af spongosin (2-methoxyadenosin) til behandling af smerte i særdeleshed hyperalgesi
BRPI0406795A (pt) Composições antiprotozoários que compreendem diclazuril
NO20091495L (no) Pyrazolopyrimidinderivat
BR0311903A (pt) Tratamento para depressão e ansiedade pela combinação de um inibidor de pde iv e um agente antidepressivo ou ansiolìtico
ATE421882T1 (de) Schnellösliches azithromycin in einzeldosisform
DK1572715T3 (da) Steroidforbindelser med antitumor-aktivitet
UY30156A1 (es) Uso de derivados de benzo-heteroarilsulfamida para el tratamiento de la migrana
UA95455C2 (ru) Макроциклические ингибиторы репликации вируса гепатита с
BRPI0510858A (pt) composição, composto e método para administrar um agente biologicamente ativo a um animal necessitando o mesmo
NZ572048A (en) Method for treatment of diarrhea-predominant irritable bowel syndrome

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.